Nymox Pharmaceutical

(OTC) NYMXF

Current Price$0.12

Market Cap$11.34M

Since IPO (1997)-98%

5 Year-92%

1 Year+2%

1 Month-18%

Nymox Pharmaceutical Financials at a Glance

Market Cap

$11.34M

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.92M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.10 (Low)

Dividend

$0.00

Beta (Volatility)

-4.10 (Low)

Price

$0.12

Volume

1,205

Open

$0.12

Price

$0.12

Volume

1,205

Open

$0.12

Previous Close

$0.12

Daily Range

$0.12 - $0.14

52-Week Range

$0.03 - $0.20

Estimated Earnings Date

Jan 1, 2026

Dividend

$0.00

Beta (Volatility)

-4.10 (Low)

Price

$0.12

Volume

1,205

Open

$0.12

Previous Close

$0.12

Daily Range

$0.12 - $0.14

52-Week Range

$0.03 - $0.20

Estimated Earnings Date

Jan 1, 2026

NYMXF News

2-Star Stocks Poised to Plunge: Nymox Pharmaceutical?

BRIAN PACAMPARANov 12, 2012

Whoa! What Just Happened to My Stock?

Rich DupreyJun 27, 2011

3 Stocks Shaking the Market

Rich DupreyJan 18, 2011

Hidden Stocks for High Returns

Rich DupreySep 20, 2010

3 Stocks Shaking the Market

Rich DupreyAug 6, 2010

3 Stocks Shaking the Market

Rich DupreyMay 26, 2010

Low-Profile Stocks for High Returns

Rich DupreyApr 26, 2010

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nymox Pharmaceutical

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Paul Averback, MD

Website

www.nymox.com

Headquarters

Nassau, BS

NYMXF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

90.31%

Return on Capital

N/A

Return on Assets

-686.85%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.34M

Shares Outstanding

94.54M

Volume

1.21K

Avg. Volume

37.01K

Financials (TTM)

Gross Profit

-$6.00K

Operating Income

-$7.31M

EBITDA

-$7.71M

Operating Cash Flow

-$3.80M

Capital Expenditure

$27.15

Free Cash Flow

-$3.80M

Cash & ST Invst.

$74.00K

Total Debt

$0.00

Nymox Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$11.34M

N/A

Market Cap/Employee

$709.05K

N/A

Employees

N/A

Net Income

-$857.00K

+22.8%

EBITDA

-$771.00K

+29.7%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Total Cash

$74.00K

-43.9%

Total Debt

$0.00

-100.0%

Accounts Receivable

$27.00K

+170.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-6.87%

N/A

Return on Invested Capital

63.22%

N/A

Free Cash Flow

-$717.00K

+27.6%

Operating Cash Flow

-$717.00K

+27.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALRTFALR Technologies Inc.

ALRTFALR Technologies Inc.$0.02-2.86%

INTIInhibitor Therapeutics, Inc.

INTIInhibitor Therapeutics, Inc.$0.08-11.11%

LVCLFAlgorae Pharmaceuticals Limited

LVCLFAlgorae Pharmaceuticals Limited$0.01+17.90%

DVHGFDevonian Health Group Inc.

DVHGFDevonian Health Group Inc.$7.00+0.00%

SRBCFSirona Biochem Corp.

SRBCFSirona Biochem Corp.$0.01+0.00%

VPHIFValeo Pharma Inc.

VPHIFValeo Pharma Inc.$0.00+0.00%

IMUCEOM Pharmaceuticals Holdings, Inc.

IMUCEOM Pharmaceuticals Holdings, Inc.$0.27+22.73%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$18.07+0.01%

TAT&T

TAT&T$20.70-0.05%

INTCIntel

INTCIntel$139.63+0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$170.86+0.04%

ONDSOndas

ONDSOndas$8.24+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.16+0.04%

PATHUiPath

PATHUiPath$10.87+0.02%

Questions About NYMXF

What is the current price of Nymox Pharmaceutical?

Nymox Pharmaceutical is trading at $0.12 per share.

What is the 52-week range for Nymox Pharmaceutical?

Over the past 52 weeks, Nymox Pharmaceutical has traded between $0.03 and $0.20.

How much debt does Nymox Pharmaceutical have?

As of the most recent reporting period, Nymox Pharmaceutical reported total debt of $3.29M.

How much cash does Nymox Pharmaceutical have on hand?

Nymox Pharmaceutical reported $74.00K in cash and cash equivalents in its most recent financial results.

What is Nymox Pharmaceutical’s dividend yield?

Nymox Pharmaceutical does not currently have a dividend yield.

Nymox Pharmaceutical

Nymox Pharmaceutical Financials at a Glance

NYMXF News

2-Star Stocks Poised to Plunge: Nymox Pharmaceutical?

Whoa! What Just Happened to My Stock?

3 Stocks Shaking the Market

Hidden Stocks for High Returns

3 Stocks Shaking the Market

3 Stocks Shaking the Market

Low-Profile Stocks for High Returns

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nymox Pharmaceutical

NYMXF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nymox Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NYMXF

What is the current price of Nymox Pharmaceutical?

What is the 52-week range for Nymox Pharmaceutical?

How much debt does Nymox Pharmaceutical have?

How much cash does Nymox Pharmaceutical have on hand?

What is Nymox Pharmaceutical’s dividend yield?

Premium Investing Services